AbbVie
ABBV
#30
Rank
HK$3.509 T
Marketcap
HK$1,987
Share price
4.20%
Change (1 day)
36.66%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of March 2026 : -HK$51.85 Billion

According to AbbVie's latest financial reports the company has -HK$51.85 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-HK$25.12 Billion-196.17%
2024-12-31$HK$26.11 B-67.84%
2023-12-31$HK$81.20 B-39.88%
2022-12-31$HK$135.06 B12.22%
2021-12-31$HK$120.36 B18.55%
2020-12-31$HK$101.53 B-259.53%
2019-12-31$-HK$63.65 Billion-3.77%
2018-12-31$-HK$66.14 Billion-266.09%
2017-12-31$HK$39.82 B10.77%
2016-12-31$HK$35.95 B17.57%
2015-12-31$HK$30.57 B126.3%
2014-12-31$HK$13.51 B-61.21%
2013-12-31$HK$34.83 B33.63%
2012-12-31$HK$26.06 B-71.87%
2011-12-31$HK$92.67 B-24.16%
2010-12-31$HK$122.20 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
HK$708.86 B-1,467.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$244.62 B-571.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$72.05 B-238.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$146.24 B-382.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$183.72 B-454.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$157.62 B-404.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$371.54 B-816.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$180.91 B-448.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$26.71 B-151.53%๐Ÿ‡บ๐Ÿ‡ธ USA